Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Market Cap	14.27B
Revenue (ttm)	5.04B
Net Income (ttm)	-847.23M
Shares Out	4.27B
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,319,892
Average Volume	4,396,712
Open	3.350
Previous Close	3.300
Day's Range	3.340 - 3.350
52-Week Range	1.510 - 3.990
Beta	-0.05
RSI	55.98
Earnings Date	Jul 30, 2025

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It operates through two segments, Pharmaceuticals and Animal Health. The company also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments. The company was formally known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1...

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 196
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: NEIMETH

Financial Performance

In 2024, NGX:NEIMETH's revenue was 4.49 billion, an increase of 102.98% compared to the previous year's 2.21 billion. Losses were -885.33 million, -50.75% less than in 2023.